| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 05/18/2010 | US7718649 Physical states of a pharmaceutical drug substance |
| 05/18/2010 | US7718647 5,6,7,8-Tetrahydro-4H-thieno[2,3-d]azepine and 4,4a,5,6,7,8-hexahydro-3H-1-thia-6-aza-cyclopenta[cd]azulene derivatives can be used to treat addiction, anxiety, depression and obesity |
| 05/18/2010 | CA2564367C Delta crystalline form of ivabradine chlorhydrate, process for its preparation and pharmaceutical compositions containing it |
| 05/14/2010 | WO2010054215A1 Methods of synthesis of benzazepine derivatives |
| 05/14/2010 | CA2742863A1 Methods of synthesis of benzazepine derivatives |
| 05/13/2010 | US20100120746 Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain |
| 05/12/2010 | EP2183218A2 Novel b1 antagonists |
| 05/11/2010 | US7713966 Heterobicyclic metalloprotease inhibitors |
| 05/11/2010 | US7713959 Affecting weight loss, increasing energy expenditure, increasing satiety; zonisamide |
| 05/11/2010 | US7713958 Compounds and compositions as protein kinase inhibitors |
| 05/06/2010 | WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 05/06/2010 | US20100113722 Sulfur chelated ruthenium compounds useful as olefin metathesis catalysts |
| 05/06/2010 | US20100113423 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof |
| 05/06/2010 | US20100113414 Thiazolyl-dihydro-indazoles |
| 05/05/2010 | EP1569929B1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 05/05/2010 | CN101701009A Method for dehydrating hexanolactam sylvite system |
| 05/04/2010 | US7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals |
| 04/29/2010 | WO2010048017A1 Disubstituted azepan orexin receptor antagonists |
| 04/29/2010 | WO2009153461A3 Method for the synthesis of 7, 8-dimethoxy-l, 3-dihydro-2h-3-benzazepin-2-one, and the application thereof to the synthesis of ivabradine and the addition salts thereof with a pharmaceutically acceptable acid |
| 04/29/2010 | US20100105894 Cyclopropane compounds and pharmaceutical use thereof |
| 04/29/2010 | US20100105658 Aza-bridged-ring compound |
| 04/29/2010 | US20100105657 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease |
| 04/29/2010 | CA2739927A1 Disubstituted azepan orexin receptor antagonists |
| 04/28/2010 | EP2178844A1 Azepine derivatives as gamma-secretase inhibitors |
| 04/28/2010 | CN1758942B Distillation method for separating hexamethylenediamine from a mixture comprising hexamethylenediamine, -aminocapronitrile and tetrahydroazepine |
| 04/27/2010 | US7704994 1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3- pyridinyl}-2-pyrrolidinone and salts; histamine H3 antagonists; Alzheimer's disease; schizophrena; antiepileptic agents; analgesics; neuropathic pain; Parkinson's disease; attention deficit disorder |
| 04/27/2010 | US7704993 9-Bromo-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine; selective serotonin receptor agonists; obesity, eating disorders, psychiatric disorders, Alzheimer Disease, sexual dysfunction; erectile dysfunction; central nervous system disorders; antidiabetic agents; gastrointestinal disorders |
| 04/27/2010 | US7704992 methyl((1S)-1-(((2S)-2-(5-(9-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-6-methyl-6,7-dihydro-5H-dibenzo[c,e]azepin-3-yl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate; inhibit the function of the non-structural proteins (NS5A) |
| 04/22/2010 | WO2010042998A1 S1p receptors modulators |
| 04/22/2010 | US20100099664 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications |
| 04/22/2010 | US20100099663 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 04/22/2010 | CA2739901A1 S1p receptors modulators |
| 04/21/2010 | CN101696191A Purifying method of N-vinyl-Epsilon-caprolactam |
| 04/21/2010 | CN101696190A Refining method of N-vinyl-Epsilon-caprolactam |
| 04/21/2010 | CN101696189A Purifying method of N-vinyl-Epsilon-caprolactam |
| 04/20/2010 | US7700767 reduce the frequency of replacing and regenerating ion-exchange resin; reduces waste; allows the ion-exchange apparatus to continue running even if an abrupt rising in the EXT.290 and/or ALK of the filtrate occurs |
| 04/20/2010 | US7700585 Derivatives of N-[phenyl(pyrrolidine-2-YL)methyl]benzamide and N-[(azepan-2-YL) phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/20/2010 | US7700583 11β-hydroxysteroid dehydrogenase type 1 active compounds |
| 04/15/2010 | WO2010041943A2 METHOD FOR PREPARING ε-CAPROLACTAM FROM N-ACYL-6-AMINOCAPROIC ACID |
| 04/15/2010 | US20100093705 Therapeutic agents, and methods of making and using the same |
| 04/13/2010 | US7696193 Such as 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide; for treatment of neurological and psychiatric disorders |
| 04/13/2010 | CA2537404C Crystalline .gamma.-d form of ivabradine hydrochloride, the process for preparing it, and the pharmaceutical compositions that contain it |
| 04/08/2010 | WO2010037257A1 New benzazepine compounds, preparation methods and uses thereof |
| 04/07/2010 | EP2170831A1 Benzazepine derivatives useful as vasopressin antagonists |
| 04/07/2010 | EP2170343A1 Treatment of age-related macular degeneration |
| 04/07/2010 | CN101691319A Method for synthesizing fluoro nitrogen heterocyclic compound |
| 04/06/2010 | US7692019 for treatment of drug addiction and pain; isomerization catalysts; combinatorial chemistry |
| 04/06/2010 | US7691845 Anti-inflammatory agents |
| 04/06/2010 | US7691844 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure |
| 04/06/2010 | US7691837 e.g. 1-{[1,5-bis(4-cholorophenyl)-2-methylpyrrol-3-yl]methyl}-4-(4-fluoro-phenyl)piperazine; Mycobacterium tuberculosis, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellulare complex, Mycobacterium fortuitum or Mycobacterium kansasi |
| 04/06/2010 | CA2496712C New process for synthesizing derivatives of 1,3,4,5-tetrahydro-2h-3-benzazepin-2-one and its application to the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts |
| 03/31/2010 | CN101687805A Benzazepine derivatives useful as vasopressin antagonists |
| 03/31/2010 | CN101686983A Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 03/31/2010 | CN101686982A Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 03/31/2010 | CN101684096A Novel benzoazepine compound and preparation method and application thereof |
| 03/31/2010 | CN100596297C Technology for extracting dihydrogalanthamine from lycoris radiata genus plant |
| 03/30/2010 | US7687494 Substituted spirobenzazepines |
| 03/30/2010 | CA2537420C Bd crystalline form of ivabradine chlorhydrate, process for the preparation thereof and pharmaceutical compounds containing it |
| 03/25/2010 | WO2010031719A1 Method for the continuous production of an amine using an aluminium-copper catalyst |
| 03/25/2010 | US20100075926 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival |
| 03/24/2010 | EP2166004A1 New method for resolution of enantiomers of (3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitrile and their application to the synthesis of ivabradine |
| 03/24/2010 | CN101679397A Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 03/18/2010 | WO2010007382A8 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 03/18/2010 | US20100069373 Substituted lactams as inhibitors of a beta protein production |
| 03/17/2010 | EP2162438A2 Process for the preparation of ivabradine hydrochloride and polymorph thereof |
| 03/17/2010 | EP2162435A1 Ionic liquids as electrolytes |
| 03/17/2010 | CN101674836A Novel dosage form |
| 03/17/2010 | CN101671303A Process for directly synthesizing caprolactam by using cyclohexanone |
| 03/17/2010 | CN101671291A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/17/2010 | CN101671265A New benzocyclobutane, preparation method thereof and application thereof |
| 03/17/2010 | CN101670291A Catalyst for synthesizing caprolactam in one step by ammoxidation of cyclohexanone and preparation and application method thereof |
| 03/16/2010 | US7678786 Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol |
| 03/16/2010 | CA2329881C Compounds with growth hormone releasing properties |
| 03/11/2010 | WO2010026989A1 Ortho-substituted haloalkylsulfonanilide derivative and herbicide |
| 03/11/2010 | WO2008146308A3 Process for the preparation of ivabradine hydrochloride and polymorph thereof |
| 03/11/2010 | US20100063274 Method for preparing amide |
| 03/11/2010 | US20100063030 Benzenesulfonyl Compounds and the Use Thereof |
| 03/10/2010 | CN100593539C Malonamide derivatives blocking the activtiy of gamma-secretase |
| 03/09/2010 | US7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 03/09/2010 | US7674787 Conformationally constrained Smac mimetics and the uses thereof |
| 03/04/2010 | WO2010023383A1 Novel method for resolving the enantiomers of (3,4-dimethoxybicyclo[4.2.0]octa-13,5-trien-7-yl)nitrile and use in the synthesis of ivabradine |
| 03/04/2010 | US20100056778 Process for the resolution of enantiomers of (3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl) nitrile and application in the synthesis of ivabradine |
| 03/04/2010 | US20100056777 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring |
| 03/04/2010 | US20100056501 Substituted lactams as inhibitors of abeta protein production |
| 03/04/2010 | US20100056497 Amide derivative |
| 03/04/2010 | US20100056496 Muscarinic receptor antagonists |
| 03/04/2010 | US20100051106 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/25/2010 | WO2010021149A1 Spiro compound capable of inhibiting acid secretion |
| 02/25/2010 | US20100048665 3-aminopyrrolidone derivatives |
| 02/25/2010 | US20100048541 Substituted lactams as inhibitors of abeta protein production |
| 02/25/2010 | US20100045170 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/25/2010 | DE102008044452A1 Kontinuierliches Verfahren zur Extraktion von Polyamid-6 A continuous process for the extraction of polyamide-6 |
| 02/24/2010 | CN101654437A Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds |
| 02/24/2010 | CN101654436A Method for producing epsilon caprolactam and method for producing pentasil type zeolite |
| 02/24/2010 | CN100591689C Solid salts of benzazepine compounds and its uses in preparing pharmaceutical compound containing them |
| 02/24/2010 | CN100591672C Chemical synthesis method for oxcarbazepine |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/18/2010 | WO2009092073A3 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| 02/18/2010 | US20100041881 Optically active ammonium salt compound, production intermediate thereof, and production method thereof |
| 02/18/2010 | US20100041640 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |